Pantoprazol Durban (Pantoprazole Sodium Sesquihydrate)

Pantoprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme, commonly called the gastric proton pump, located on the secretory surface of parietal cells. Blocking this final step in acid production leads to a sustained rise in gastric pH and a decrease in the volume of acid released into the stomach.

The appropriate dose of Pantoprazol Durban is determined by the prescribing clinician based on the specific indication, severity of disease and patient characteristics. Healthcare professionals set the dosage and duration according to current clinical guidelines and individual patient needs.

Pantoprazole is classified as pregnancy category B in many regions, indicating no evidence of risk in animal studies but limited human data. It may be used during pregnancy only if clearly needed. Limited data exist for lactating mothers; a risk‑benefit assessment should be performed by the prescriber.

To place an order, visit the Pantoprazol Durban product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazol Durban belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, pantoprazole has a low potential for CYP‑mediated drug interactions, making it a suitable option for patients on multiple medications.

Store Pantoprazol Durban tablets at temperatures not exceeding 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Pantoprazol Durban is supplied as oral tablets that should be swallowed whole with a glass of water. It is usually taken before a meal, most commonly in the morning, unless the prescriber advises a different schedule based on the patient’s condition.

Serious, though uncommon, risks include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels, bone fractures with long‑term use, and acute interstitial nephritis. Patients should seek immediate medical attention if they experience symptoms such as rash, persistent diarrhea, muscle cramps or unexplained fatigue.

Pantoprazol Durban is contraindicated in individuals with known hypersensitivity to pantoprazole or any other component of the formulation. Caution is also advised for patients with severe liver impairment, those requiring certain antifungal or antiviral therapies, and anyone who has experienced a severe reaction to other proton pump inhibitors.